Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SROM vs Methadone for Opioid Use Disorder
NCT03948464Phase 3Terminated
- Start
- Dec 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of morphine in opioid use disorder (OUD) (2 arms). Primary endpoint: Opioid Use at 24 weeks. Started Dec 2019; status: terminated.
02
Drugs
morphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03948464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03948464.